The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen Research & Development; Roche
Research Funding - Celgene; Janssen Research & Development
Travel, Accommodations, Expenses - Janssen Research & Development; Roche
Ibrutinib (I) plus bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a 2-year follow-up of the HELIOS study.
 
Graeme Fraser
Honoraria - Celgene; Janssen Research & Development; Lundbeck; Roche
Consulting or Advisory Role - Roche
Speakers' Bureau - Janssen Research & Development
Research Funding - Celgene; Janssen Research & Development
 
Paula Cramer
Speakers' Bureau - Janssen Research & Development; Roche
Research Funding - Gilead Sciences; GlaxoSmithKline; Janssen Research & Development; Roche
Travel, Accommodations, Expenses - Astellas Pharma; Gilead Sciences; Janssen Research & Development; Mundipharma; Roche
 
Fatih Demirkan
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Celgene
 
Rodrigo Santucci Silva
Research Funding - Celgene; GlaxoSmithKline; Janssen Research & Development; Merck; Roche
Travel, Accommodations, Expenses - Janssen Research & Development; Novartis; Roche
 
Halyna Pylypenko
No Relationships to Disclose
 
Sebastian Grosicki
No Relationships to Disclose
 
Ann Janssens
Consulting or Advisory Role - Janssen Research & Development; Roche
Speakers' Bureau - Mundipharma; Roche
 
Aleksander Pristupa
No Relationships to Disclose
 
Jiri Mayer
Research Funding - Janssen Research & Development
 
Marie-Sarah Dilhuydy
Honoraria - Gilead Sciences; Janssen Research & Development; Roche
Speakers' Bureau - Gilead Sciences; Janssen Research & Development
Travel, Accommodations, Expenses - Janssen Research & Development; Roche
 
Javier Loscertales
Consulting or Advisory Role - Abbvie; Amgen; Gilead Sciences; Janssen Research & Development; Mundipharma; Roche
 
Andre Goy
Honoraria - Acerta Pharma; Celgene; Pharmacyclics; Takeda
Consulting or Advisory Role - Acerta Pharma; Celgene; Infinity Pharmaceuticals; Pharmacyclics; Takeda
Speakers' Bureau - Pharmacyclics; Takeda
Research Funding - Clinical Trials Through Institution
 
Abraham Avigdor
Consulting or Advisory Role - Janssen Research & Development; Johnson & Johnson
 
Simon Rule
No Relationships to Disclose
 
Charles Phelps
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Michelle Mahler
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Mariya Salman
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Angela J. Howes
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Sriram Balasubramanian
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Abbvie; Johnson & Johnson
 
Asher Alban Akmal Chanan-Khan
No Relationships to Disclose